Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ujhelyi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Pharmacology|April 30, 2003
Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersionJ Jason Sims, Allison W Miller, Michael R Ujhelyi
Journal of Cardiovascular Electrophysiology|July 11, 2002
Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide deliveryMichael R Ujhelyi, Kelly Z Hadsall, David E Euler, et al.
Heart & Lung : the Journal of Critical Care|October 7, 2003
Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapyChristi Deaton, Sandra B Dunbar, Margaret Moloney, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 22, 2006
Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillatorsDavid Schwartzman, Mark N Harvey, Robert H Hoyt, et al.
Pacing and Clinical Electrophysiology : PACE|August 18, 2005
Understanding atrial symptom reports: objective versus subjective predictorsSamuel F Sears, Eva R Serber, Luis G Alvarez, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 11, 2008
Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmiasYong-Fu Xiao, Daniel C Sigg, Michael R Ujhelyi, et al.
Circulation|May 17, 2006
Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation?Daniel C Sigg, Prasanga Hiniduma-Lokuge, James A Coles, et al.
Journal of Cardiovascular Electrophysiology|March 20, 2004
Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) StudyJason L Burns, Samuel F Sears, Rebecca Sotile, et al.
Journal of Cardiovascular Electrophysiology|February 23, 2007
Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervalsVadim Levin, Margit Nemeth, Ilyas Colombowala, et al.
Circulation|June 16, 2005
Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine modelZiad F Issa, Xiaohong Zhou, Michael R Ujhelyi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology|April 30, 2003
Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersionJ Jason Sims, Allison W Miller, Michael R Ujhelyi
Journal of Cardiovascular Electrophysiology|July 11, 2002
Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide deliveryMichael R Ujhelyi, Kelly Z Hadsall, David E Euler, et al.
Heart & Lung : the Journal of Critical Care|October 7, 2003
Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapyChristi Deaton, Sandra B Dunbar, Margaret Moloney, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 22, 2006
Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillatorsDavid Schwartzman, Mark N Harvey, Robert H Hoyt, et al.
Pacing and Clinical Electrophysiology : PACE|August 18, 2005
Understanding atrial symptom reports: objective versus subjective predictorsSamuel F Sears, Eva R Serber, Luis G Alvarez, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 11, 2008
Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmiasYong-Fu Xiao, Daniel C Sigg, Michael R Ujhelyi, et al.
Circulation|May 17, 2006
Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation?Daniel C Sigg, Prasanga Hiniduma-Lokuge, James A Coles, et al.
Journal of Cardiovascular Electrophysiology|March 20, 2004
Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) StudyJason L Burns, Samuel F Sears, Rebecca Sotile, et al.
Journal of Cardiovascular Electrophysiology|February 23, 2007
Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervalsVadim Levin, Margit Nemeth, Ilyas Colombowala, et al.
Circulation|June 16, 2005
Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine modelZiad F Issa, Xiaohong Zhou, Michael R Ujhelyi, et al.
Pageof 2